Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

INTRODUCTION: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is known to be chemosensitive. In patients with TNBC, we sought to compare survival outcomes between patients receiving neoadjuvant chemotherapy, with and without complete pathologic response (pCR), and...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Fisher, Carla S., Ma, Cynthia X., Gillanders, William E., Aft, Rebecca L., Eberlein, Timothy J., Gao, Feng, Margenthaler, Julie A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3892697/
https://ncbi.nlm.nih.gov/pubmed/21725686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-011-1877-y
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים